NANOSPHERES TARGET DYES AND DRUGS FOR CELLULAR RESEARCH

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 8108
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1988
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
305 Fawn Meadows, Ballwin, MO, 63011
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE CENTRAL PURPOSE OF THIS RESEARCH IS TO DEVELOP A FLEXIBLE SYSTEM FOR SELECTIVE DELIVERY OF FLUORESCENT DYES, PHOTOACTIVE AGENTS, AND DRUGS TO SUBPOPULATIONS OF NEURONS DEEP WITHIN THE RODENT NERVOUS SYSTEM IN VIVO. A NOVEL LATEX NANOSPHERE DELIVERY SYSTEM (LNDS) WILL BE DEVELOPED AND REFINED TO ALLOW NEUROANATOMICAL, DEVELOPMENTAL, AND PHARMACOLOGIC STUDIES. DURING PHASE I, THE LNDS WILL BE DEVELOPED AS A NEUROANATOMICAL RESEARCH TOOL. PHASE II WOULD CONTINUE THESE RESEARCH AND DEVELOPMENT EFFORTS WHILE EMPHASIZING DEVELOPMENT OF SELECTIVE DRUG DELIVERY VIA THE LNDS. FLUORESCENT DYES AND PHOTOACTIVE AGENTS WILL BE INCORPORATED WITHIN LATEX NANOSPHERES OF DEFINED SIZE, SURFACE PROPERTIES, AND NEURONAL SELECTIVITY. NANOSPHERE TRANSPORT WITHIN THE RODENT NERVOUS SYSTEM WILL BE QUANTIFIED. SPECIFIC AIM I WILL BE DIRECTED TOWARD THE FABRICATION AND OPTIMIZATION OF SEVERAL TYPES OF LNDS. SPECIFIC AIM II WILL FOCUS ON ANALYSIS AND CHARACTERIZATION OF THE NANOSPHERES. SPECIFIC AIMS III AND IV INVOLVE ASSESSMENT OF UPTAKE BY CULTURED RAT NEOCORTICAL NEURONS PRIOR TO QUALITATIVE AND QUANTITATIVE ASSESSMENT OF TRANSPORT BY THE LNDS WITHIN TWO MODEL SYSTEMS: CALLOSAL PROJECTIONS TO MOTOR CORTEX AND RETINAL GANGLION CELL PROJECTIONS TO SUPERIOR COLLICULUS IN RODENTS. PRELIMINARY STUDIES HAVE DEMONSTRATED LNDS PRODUCTION, ANALYSES, AND BIOLOGICAL TRANSPORT. THUS, THE STAGE IS SET TO DEVELOP THIS UNIQUELY POWERFUL METHODOLOGY TO PRODUCE UNIFORM, SUBMICRON PARTICLES FOR SELECTIVE CELL TARGETING. THE NEUROSCIENCES COMMUNITY IN PARTICULAR AND THE BIOMEDICALCOMMUNITY IN GENERAL WILL BENEFIT FROM A GENERALLY APPLICABLE LNDS TECHNOLOGY. IT IS ESTIMATED THAT APPROXIMATELY 5,000-10,000 NEUROSCIENTISTS WOULD PURCHASE SUCH PRODUCTS IN THE FIRST YEAR ALONE FOR APPLICATION TOWARDTHE STUDY OF DEVELOPMENT, REGENERATION, AND TRANSPLANTATION WITHIN THE CNS.. THE POTENTIAL FOR CELL SPECIFIC DRUG DELIVERY SYSTEMS IS OF CLEARLY LARGE COMMERCIAL INTEREST.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government